{
  "docId": "019de516-9989-7672-a652-fe437099830c",
  "docSlug": "dc4b6dd31d750eecf6a392f7e2ae4db2",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 22 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 22,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "product_demo",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 7,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-9989-7672-a652-fe437099830c/9",
  "deckHref": "/decks/019de516-9989-7672-a652-fe437099830c",
  "deckJsonHref": "/decks/019de516-9989-7672-a652-fe437099830c.json",
  "deckAnchorHref": "/decks/019de516-9989-7672-a652-fe437099830c#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.259,
        "w": 0.13,
        "x": 0.682,
        "y": 0.249
      },
      "kind": "image",
      "text": "GTx Full scale RUO/cGMP",
      "attrs": {},
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "312fa32b-fafb-49ea-9666-219b73512d60",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.259,
        "w": 0.13,
        "x": 0.825,
        "y": 0.249
      },
      "kind": "image",
      "text": "VLx Large Scale RUO/cGMP",
      "attrs": {},
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a74134e-33ba-4fdf-b75d-86d3eeb8f806",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.259,
        "w": 0.13,
        "x": 0.539,
        "y": 0.249
      },
      "kind": "image",
      "text": "STx Full scale RUO",
      "attrs": {},
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a7810fc-a5c6-4f24-986c-673dca432cb6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.259,
        "w": 0.13,
        "x": 0.396,
        "y": 0.249
      },
      "kind": "image",
      "text": "ATx Small/mid-scale RUO",
      "attrs": {},
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dfb705c9-8da9-448a-8fcb-b6eacf52d4ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.21,
        "w": 0.13,
        "x": 0.825,
        "y": 0.58
      },
      "kind": "list",
      "text": "High Quality:\nSterile, single-use processing assemblies (PAs)\nClosed, cGMP-compliant, ISO-certified, and CE marked instruments\nSupported by US FDA Master File and global equivalents",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4063df84-5eda-49ed-ae52-f86ccc6f4512",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.66,
        "w": 0.346,
        "x": 0.042,
        "y": 0.194
      },
      "kind": "list",
      "text": "Launched in 2019 based on MaxCyte's proprietary Flow Electroporation® technology and has been optimized for the past 20+ years\nLeverages the reversible permeability of the cell membrane in response to an electric charge\nUniversally delivers molecules, such as nucleic acids, gene-editing tools and proteins, into cells\nAgnostic to cell type, approach (auto/allo) and/or gene manipulation technology\nEnables customers to use a single platform from concept through to the clinic in a GMP environment\nSupported by a robust intellectual property portfolio (150+ patents granted in US and foreign jurisdictions and 95+ patents pending worldwide)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5274af22-1e98-412c-be46-b2c9e03f4407",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.21,
        "w": 0.14,
        "x": 0.671,
        "y": 0.58
      },
      "kind": "list",
      "text": "Scalability – Ability to Transfect:\n75,000 to 7 million cells in seconds\nUp to 20 billion cells in less than 30 minutes\nAnd up to 200 billion cells in less than 30 minutes with the high scale VLx",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "685a86af-1acc-4168-a8c7-6eb9bf8820ac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.21,
        "w": 0.129,
        "x": 0.409,
        "y": 0.58
      },
      "kind": "list",
      "text": "High Performance:\n>90% transfection efficiencies (depending on cell type and molecule)\n>90% cell viabilities\nComputer-controlled system for reproducible results",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "86d2e051-b171-4f1e-81c4-aa7537b0a199",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.184,
        "w": 0.129,
        "x": 0.54,
        "y": 0.58
      },
      "kind": "list",
      "text": "Flexibility:\nSingle, fully-defined, animal component-free electroporation buffer for all cell types\nPre-loaded library of validated, cell-specific protocols",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a4ed2343-ef8a-44ff-ada6-4471aa7219cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.154,
        "x": 0.823,
        "y": 0.963
      },
      "kind": "source-note",
      "text": "© 2023 MaxCyte, Inc. All Rights Reserved",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "01bd5d88-1dc1-4c8e-9006-0c445914d1fb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.706,
        "x": 0.042,
        "y": 0.08
      },
      "kind": "title",
      "text": "The EXPERT™ Platform Enabling Non-Viral Cell Engineering",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbd41d5c-c496-4738-aad0-13661be0a07f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.017,
        "w": 0.276,
        "x": 0.409,
        "y": 0.18
      },
      "kind": "title",
      "text": "EXPERT™ Instrument Portfolio",
      "attrs": {},
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cdd7d2c4-b221-42e6-8607-b49dbae57712",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 6,
      "beatId": "d4f7f81d-15bd-4167-9e08-bd7e1ed530d3",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Business Model",
      "beatSlug": "sequoia-pitch-business-model",
      "evidence": "The business model is explained on pages 6 and 10-11",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 8,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "05808251-1f37-4b02-94c7-b48dd5da10b5",
      "evidence": "The problem statement on page 8 implies the cost of inaction",
      "position": 0,
      "objective": "Highlight the challenges of not using MaxCyte's platform",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}